Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

J Cyst Fibros. 2022 Mar;21(2):227-229. doi: 10.1016/j.jcf.2021.07.017. Epub 2021 Aug 9.

¹ Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, United States. Electronic address: [email protected].
² Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, United States.
³ Center for Liver Disease and Transplantation, Columbia University, New York, NY, United States.
⁴ Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
⁵ Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States.

No abstract available

Keywords: CFTR modulator; Cystic fibrosis; Liver transplantation.

Publication types